| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 26.72B | 28.20B | 26.57B | 27.92B | 29.66B | 31.33B |
| Gross Profit | 6.95B | 7.59B | 6.85B | 6.62B | 7.01B | 6.52B |
| EBITDA | 3.00B | 3.14B | 3.17B | 3.09B | 3.25B | 3.15B |
| Net Income | 2.07B | 2.38B | 2.08B | 2.00B | 2.11B | 2.01B |
Balance Sheet | ||||||
| Total Assets | 30.99B | 32.95B | 33.26B | 32.57B | 31.92B | 31.39B |
| Cash, Cash Equivalents and Short-Term Investments | 4.07B | 5.66B | 5.73B | 4.65B | 5.53B | 4.45B |
| Total Debt | 4.41B | 2.97B | 4.04B | 4.24B | 5.03B | 5.07B |
| Total Liabilities | 9.25B | 9.52B | 11.39B | 11.11B | 11.82B | 12.23B |
| Stockholders Equity | 21.73B | 23.43B | 21.86B | 21.45B | 20.10B | 19.16B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 2.06B | 2.80B | 660.00M | 2.50B | 821.00M |
| Operating Cash Flow | 0.00 | 2.14B | 2.84B | 717.00M | 2.54B | 886.00M |
| Investing Cash Flow | 0.00 | 25.00M | 140.00M | 25.00M | -206.00M | -5.00M |
| Financing Cash Flow | 0.00 | -2.23B | -1.90B | -1.63B | -1.25B | -1.11B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
69 Neutral | ¥17.13B | 8.47 | ― | 4.04% | 6.15% | 17.27% | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% | |
59 Neutral | ¥73.70B | 14.12 | ― | 2.98% | 11.53% | 17.06% | |
56 Neutral | ¥37.18B | 17.99 | ― | 9.18% | -28.55% | ― | |
51 Neutral | ¥13.99B | 7.31 | -111.61% | ― | -0.57% | ― | |
48 Neutral | ¥81.36B | 35.50 | ― | 1.38% | -9.56% | -63.67% | |
47 Neutral | ¥188.25B | 58.58 | 5.78% | 1.49% | -6.28% | -23.60% |